Search

everythinglearnresearchcommunity

for

Search:↓

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Cyproterone acetate reduces hair growth and oil production.

Hormones control keratin production in skin and hair.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Endocrine diseases in dogs often cause skin problems, with hypothyroidism and hyperadrenocorticism being common and leading to hair loss and infections.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.